Mindfulness may ease stress and anxiety in COPD patients, small study suggests

NCT ID NCT07593521

Symptom relief Sponsor: Université Libre de Bruxelles Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether an 8-week mindfulness program (MBSR) can reduce anxiety, depression, and stress in people with COPD who are already in pulmonary rehab. About 44 participants will be followed for 12 months. The goal is to see if this mind-body approach improves emotional well-being and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: Mindfulness-Based Stress Reduction (MBSR) program
What this could lead to: If it works, this could point toward a low-cost, drug-free way to help COPD patients feel less anxious and stressed, and improve their quality of life.
What could go wrong: This is a very small pilot study (44 people) with no blinding, so results may not be reliable or apply to everyone. The control group was not balanced by gender initially, which could skew findings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

44 people

The number who actually took part.

Started

Sep 2015

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * a confirmed diagnosis of COPD with airflow obstruction, based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria , regardless of age, - participation in a pulmonary rehabilitation program either at hospital or at home with a physiotherapist, in accordance with GOLD recommendations * ability to read and write in French * availability of easy transportation to attend weekly classes. Exclusion Criteria: * severe exacerbation of COPD within the previous four weeks prior * presence of any active oncological disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder chronic obstructive pulmonary disease depressive disorder psychiatric disorder Psychological Well-Being Respiration Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Chronic obstructive pulmonary disease (COPD) Depression disorders Stress

Mindfulness may ease stress and anxiety in COPD patients, small study suggests

What the study statuses mean